Bill Gates, Jeff Bezos and other billionaires are heading a $100 million research effort to develop better Alzheimer’s biomarkers. Even though Alzheimer’s may start…
At this year’s AAIC, the developer of an Alzheimer’s blood test debuts promising data, while the Alzheimer’s Association warns new blood-based biomarkers aren’t quite…
Race is a biological variable for Alzheimer’s risk that scientists are still working to understand. In the meantime, experimental diagnostic methods, like blood tests,…
Using the blue device (pictured) that performs the ultrasensitive proximity extension assay technology, Professor Nancy Ip Yuk-Yu and her team have developed a blood…
The first ever commercial Alzheimer’s blood test is on the market. It’s big progress. Some experts have reservations because it hasn’t yet secured FDA…
In studies, blood tests to detect Alzheimer’s are showing promise: over the course of years of testing, they are proving to be accurate means…
Currently, Alzheimer’s disease and other dementias are typically detected and diagnosed through memory and cognitive tests or MRI and PET scans of the brain,…